BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23102520)

  • 1. Current questions for the treatment of advanced gastric cancer.
    Cervantes A; Roda D; Tarazona N; Roselló S; Pérez-Fidalgo JA
    Cancer Treat Rev; 2013 Feb; 39(1):60-7. PubMed ID: 23102520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer.
    Garrido M; Fonseca PJ; Vieitez JM; Frunza M; Lacave AJ
    Expert Rev Anticancer Ther; 2014 Aug; 14(8):887-900. PubMed ID: 24953238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of chemotherapy in metastatic gastric cancer.
    Pasini F; Fraccon AP; DE Manzoni G
    Anticancer Res; 2011 Oct; 31(10):3543-54. PubMed ID: 21965776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular-targeted therapy for chemotherapy-refractory gastric cancer: a case report and literature review.
    Kuo HY; Yeh KH
    Anticancer Res; 2014 Jul; 34(7):3695-9. PubMed ID: 24982389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target.
    De Vita F; Giuliani F; Silvestris N; Catalano G; Ciardiello F; Orditura M
    Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S11-5. PubMed ID: 21129604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographic differences in approach to advanced gastric cancer: Is there a standard approach?
    Kim R; Tan A; Choi M; El-Rayes BF
    Crit Rev Oncol Hematol; 2013 Nov; 88(2):416-26. PubMed ID: 23764501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives for personalization in chemotherapy of advanced gastric cancer.
    Boku N
    Discov Med; 2010 Feb; 9(45):84-9. PubMed ID: 20193632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular targeting agents for advanced or recurrent gastric cancer patients].
    Fuse N
    Nihon Rinsho; 2012 Oct; 70(10):1819-26. PubMed ID: 23198568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two cases of unresectable advanced gastric cancer treated with S-1, CDDP and trastuzumab].
    Ogino T; Kawamura M; Tsutsumi K; Sakamoto N; Kodama H; Machida T; Takahashi T; Takanashi S; Nakamura Y; Ishii R
    Gan To Kagaku Ryoho; 2013 Feb; 40(2):237-40. PubMed ID: 23411963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination 5-fluoruracil/cisplatinum versus 5-fluoruracil/leucovorin adjuvant chemotherapy efficacy for R0 gastric resection in locally invasive gastric cancer.
    Yamada S; Ritchim P; Charkrabandhu T; Jongraksat W
    J Med Assoc Thai; 2012 Dec; 95(12):1517-23. PubMed ID: 23390781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trastuzumab for gastric cancer.
    Meza-Junco J; Au HJ; Sawyer MB
    Expert Opin Biol Ther; 2009 Dec; 9(12):1543-51. PubMed ID: 19916733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of the unresectable non small cell lung carcinoma].
    Spásová I
    Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of gastric cancer.
    Moehler M; Galle PR; Gockel I; Junginger T; Schmidberger H
    Best Pract Res Clin Gastroenterol; 2007; 21(6):965-81. PubMed ID: 18070698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T).
    Weissinger F; Reymond M; Dumke K; Krüger M
    Onkologie; 2011; 34(10):548-51. PubMed ID: 21985855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future perspectives for the development of chemotherapy for advanced gastric cancer: Japanese and global status.
    Higuchi K; Tanabe S; Azuma M; Sasaki T; Ishido K; Koizumi W
    Pathobiology; 2011; 78(6):334-42. PubMed ID: 22104205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of capecitabine and irinotecan combination therapy in advanced or metastatic gastric cancer.
    Farhat FS; Kattan J; Ghosn MG
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):541-8. PubMed ID: 20397919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trastuzumab in gastric cancer.
    Okines AF; Cunningham D
    Eur J Cancer; 2010 Jul; 46(11):1949-59. PubMed ID: 20542421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic chemotherapy in advanced non-small cell lung cancer: a review of standard treatment paradigms.
    Socinski MA
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4210s-4214s. PubMed ID: 15217960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.